Downregulated VISTA enhances Th17 differentiation and aggravates inflammation in patients with acute-on-chronic liver failure

Moreau R, Jalan R, Gines P, et al. CANONIC Study Investigators of the EASL–CLIF Consortium. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013;144:1426–1437

Article  PubMed  Google Scholar 

Zaccherini G, Weiss E, Moreau R. Acute-on-chronic liver failure: definitions, pathophysiology and principles of treatment. JHEP Rep. 2021;3: 100176

Article  PubMed  Google Scholar 

Laleman W, Claria J, Van der Merwe S, et al. Systemic inflammation and acute-on-chronic liver failure: too much not enough. Can J Gastroenterol Hepatol. 2018;2018:1027152

Article  PubMed  PubMed Central  Google Scholar 

Zhang GL, Xie DY, Lin BL, et al. Imbalance of interleukin-17-producing CD4 T cells/regulatory T cells axis occurs in remission stage of patients with hepatitis B virus-related acute-on-chronic liver failure. J Gastroenterol Hepatol. 2013;28:513–521

Article  CAS  PubMed  Google Scholar 

Li Q, Wang J, Lu M, et al. Acute-on-chronic liver failure from chronic-hepatitis-B, who is the behind scenes. Front Microbiol. 2020;11: 583423

Article  PubMed  PubMed Central  Google Scholar 

Zhou X, Li Y, Ji Y, et al. PD-1 involvement in peripheral blood CD8+ T lymphocyte dysfunction in patients with acute-on-chronic liver failure. J Clin Transl Hepatol. 2021;9:283–290

PubMed  PubMed Central  Google Scholar 

Wang L, Rubinstein R, Lines JL, et al. VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses. J Exp Med. 2011;208:577–592

Article  CAS  PubMed  PubMed Central  Google Scholar 

Flies DB, Wang S, Xu H, et al. Cutting edge: a monoclonal antibody specific for the programmed death-1 homolog prevents graft-versus-host disease in mouse models. J Immunol. 2011;187:1537–1541

Article  CAS  PubMed  Google Scholar 

Kunishige T, Taniguchi H, Ohno T, et al. VISTA is crucial for corneal allograft survival and maintenance of immune privilege. Invest Ophthalmol Vis Sci. 2019;60:4958–4965

Article  CAS  PubMed  Google Scholar 

Flies DB, Han X, Higuchi T, et al. Coinhibitory receptor PD-1H preferentially suppresses CD4(+) T cell-mediated immunity. J Clin Invest. 2014;124:1966–1975

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang L, Le Mercier I, Putra J, et al. Disruption of the immune-checkpoint VISTA gene imparts a proinflammatory phenotype with predisposition to the development of autoimmunity. Proc Natl Acad Sci U S A. 2014;111:14846–14851

Article  CAS  PubMed  PubMed Central  Google Scholar 

Derakhshani A, Asadzadeh Z, Baradaran B, et al. The expression pattern of VISTA in the PBMCs of relapsing-remitting multiple sclerosis patients: a single-cell RNA sequencing-based study. Biomed Pharmacother. 2022;148: 112725

Article  CAS  PubMed  Google Scholar 

Hid Cadena R, Reitsema RD, Huitema MG, et al. Decreased expression of negative immune checkpoint VISTA by CD4+ T Cells Facilitates T Helper 1, T Helper 17, and T follicular helper lineage differentiation in GCA. Front Immunol. 2019;10:1638

Article  PubMed  PubMed Central  Google Scholar 

Ceeraz S, Sergent PA, Plummer SF, et al. VISTA deficiency accelerates the development of fatal murine lupus nephritis. Arthritis Rheumatol. 2017;69:814–825

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sarin SK, Choudhury A, Sharma MK, et al. APASL ACLF Research Consortium (AARC) for APASL ACLF working party. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. Hepatol Int. 2019;13:353–390

Article  PubMed  Google Scholar 

Kamath PS, Kim WR. The model for end-stage liver disease (MELD). Hepatology. 2007;4:797–805

Article  Google Scholar 

Biggins SW, Kim WR, Terrault NA, et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology. 2006;130:1652–1660

Article  PubMed  Google Scholar 

Jalan R, Saliba F, Pavesi M, et al. CANONIC study investigators of the EASL-CLIF Consortium. Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure. J Hepatol. 2014;61:1038–1047

Article  PubMed  Google Scholar 

Sarin SK, Choudhury A. Acute-on-chronic liver failure: terminology, mechanisms and management. Nat Rev Gastroenterol Hepatol. 2016;13:131–149

Article  CAS  PubMed  Google Scholar 

Wang LY, Meng QH, Zou ZQ, et al. Increased frequency of circulating Th17 cells in acute-on-chronic hepatitis B liver failure. Dig Dis Sci. 2012;57:667–674

Article  CAS  PubMed  Google Scholar 

Xu C, Lu Y, Zheng X, et al. TLR2 expression in peripheral CD4+ T cells promotes Th17 response and is associated with disease aggravation of hepatitis B virus-related acute-on-chronic liver failure. Front Immunol. 2017;8:1609

Article  PubMed  PubMed Central  Google Scholar 

Harris TJ, Grosso JF, Yen HR, et al. Cutting edge: an in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity. J Immunol. 2007;179:4313–4317

Article  CAS  PubMed  Google Scholar 

Xiang X, Feng D, Hwang S, et al. Interleukin-22 ameliorates acute-on-chronic liver failure by reprogramming impaired regeneration pathways in mice. J Hepatol. 2020;72:736–745

Article  CAS  PubMed  Google Scholar 

Triantafyllou E, Woollard KJ, McPhail MJW, et al. The role of monocytes and macrophages in acute and acute-on-chronic liver failure. Front Immunol. 2018;9:2948

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bharaj P, Chahar HS, Alozie OK, et al. Characterization of programmed death-1 homologue-1 (PD-1H) expression and function in normal and HIV infected individuals. PLoS ONE. 2014;9: e109103

Article  PubMed  PubMed Central  Google Scholar 

Rogers BM, Smith L, Dezso Z, et al. VISTA is an activating receptor in human monocytes. J Exp Med. 2021;218: e20201601

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bharaj P, Ye C, Petersen S, et al. Gene array analysis of PD-1H overexpressing monocytes reveals a pro-inflammatory profile. Heliyon. 2018;4: e00545

Article  PubMed  PubMed Central  Google Scholar 

ElTanbouly MA, Zhao Y, Schaafsma E, et al. VISTA: a target to manage the innate cytokine storm. Front Immunol. 2021;11: 595950

Article  PubMed  PubMed Central  Google Scholar 

ElTanbouly MA, Zhao Y, Nowak E, et al. VISTA is a checkpoint regulator for naïve T cell quiescence and peripheral tolerance. Science. 2020;367:eaay0524

Article  CAS  PubMed  PubMed Central  Google Scholar 

Seto WK, Lai CL, Yuen MF. Acute-on-chronic liver failure in chronic hepatitis B. J Gastroenterol Hepatol. 2012;27:662–669

Article  PubMed  Google Scholar 

Xu W, Hiếu T, Malarkannan S, et al. The structure, expression, and multifaceted role of immune-checkpoint protein VISTA as a critical regulator of anti-tumor immunity, autoimmunity, and inflammation. Cell Mol Immunol. 2018;15:438–446

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li N, Xu W, Yuan Y, et al. Immune-checkpoint protein VISTA critically regulates the IL-23/IL-17 inflammatory axis. Sci Rep. 2017;7:1485

Article  PubMed  PubMed Central  Google Scholar 

Zhang M, Zhou L, Xu Y, et al. A STAT3 palmitoylation cycle promotes T17 differentiation and colitis. Nature. 2020;586:434–439

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nautiyal N, Maheshwari D, Tripathi DM, et al. Establishment of a murine model of acute-on-chronic liver failure with multi-organ dysfunction. Hepatol Int. 2021;15:1389–1401

Article  PubMed  Google Scholar 

Flies DB, Higuchi T, Chen L. Mechanistic assessment of PD-1H coinhibitory receptor-induced T cell tolerance to allogeneic antigens. J Immunol. 2015;194:5294–5304

Article  CAS  PubMed  Google Scholar 

Delaney B, Strom SC, Collins S, et al. Carbon tetrachloride suppresses T-cell-dependent immune responses by induction of transforming growth factor-beta 1. Toxicol Appl Pharmacol. 1994;126:98–107

Article  CAS  PubMed  Google Scholar 

Radaeva S, Sun R, Pan HN, et al. Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation. Hepatology. 2004;39:1332–1342

Article  CAS  PubMed 

留言 (0)

沒有登入
gif